RSS-Feed abonnieren
DOI: 10.1055/s-0041-1725032
Vision Deterioration and Hydrocephalus: Rare Presentations of Vestibular Schwannoma and Evolution of Management
Funding None.![](https://www.thieme-connect.de/media/jnlsb/2022S02/lookinside/thumbnails/10-1055-s-0041-1725032_200310-1.jpg)
Abstract
Introduction The incidence of vestibular schwannoma is reported as 12 to 54 new cases per million per year, increasing over time. These patients usually present with unilateral sensorineural hearing loss, tinnitus, or vertigo. Rarely, these patients present with symptoms of hydrocephalus or vision changes.
Objective The study aimed to evaluate the surgical management of vestibular schwannoma at a single institution and to identify factors that may contribute to hydrocephalus, papilledema, and the need for pre-resection diversion of cerebrospinal fluid.
Patients and Methods A retrospective review examining the data of 203 patients with vestibular schwannoma managed with surgical resection from May 2008 to May 2020. We stratified patients into five different groups to analyze: tumors with a diameter of ≥40 mm, clinical evidence of hydrocephalus, and of papilledema, and patients who underwent pre-resection cerebrospinal fluid (CSF) diversion.
Results From May 2008 to May 2020, 203 patients were treated with surgical resection. Patients with tumors ≥40 mm were more likely to present with visual symptoms (p < 0.001). Presentation with hydrocephalus was associated with larger tumor size (p < 0.001) as well as concomitant visual symptoms and papilledema (p < 0.001). Patients with visual symptoms presented at a younger age (p = 0.002) and with larger tumors (p < 0.001).
Conclusion This case series highlights the rare presentation of vision changes and hydrocephalus in patients with vestibular schwannoma. We recommend urgent CSF diversion for patients with visual symptoms and hydrocephalus, followed by definitive resection. Further, vision may still deteriorate even after CSF diversion and tumor resection.
Keywords
acoustic neuroma - vestibular schwannoma - hydrocephalus - visual deterioration - papilledema - cerebellopontine anglePublikationsverlauf
Eingereicht: 28. August 2020
Angenommen: 23. Dezember 2020
Artikel online veröffentlicht:
08. März 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Reznitsky M, Petersen MMBS, West N, Stangerup SE, Cayé-Thomasen P. Epidemiology of vestibular schwannomas - prospective 40-year data from an unselected national cohort. Clin Epidemiol 2019; 11: 981-986
- 2 Kleijwegt M, Ho V, Visser O, Godefroy W, van der Mey A. Real incidence of vestibular schwannoma? Estimations from a national registry. Otol Neurotol 2016; 37 (09) 1411-1417
- 3 Koo M, Lai JT, Yang EY, Liu TC, Hwang JH. Incidence of vestibular schwannoma in taiwan from 2001 to 2012: a population-based national health insurance study. Ann Otol Rhinol Laryngol 2018; 127 (10) 694-697
- 4 Marinelli JP, Lohse CM, Carlson ML. Incidence of vestibular schwannoma over the past half-century: a population-based study of Olmsted County, Minnesota. Otolaryngol Head Neck Surg 2018; 159 (04) 717-723
- 5 Babu R, Sharma R, Bagley JH, Hatef J, Friedman AH, Adamson C. Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 2013; 119 (01) 121-130
- 6 Pinna MH, Bento RF, Neto RV. Vestibular schwannoma: 825 cases from a 25-year experience. Int Arch Otorhinolaryngol 2012; 16 (04) 466-475
- 7 Pirouzmand F, Tator CH, Rutka J. Management of hydrocephalus associated with vestibular schwannoma and other cerebellopontine angle tumors. Neurosurgery 2001; 48 (06) 1246-1253 , discussion 1253–1254
- 8 Gerganov VM, Pirayesh A, Nouri M. et al. Hydrocephalus associated with vestibular schwannomas: management options and factors predicting the outcome. J Neurosurg 2011; 114 (05) 1209-1215
- 9 Bloch J, Vernet O, Aubé M, Villemure JG. Non-obstructive hydrocephalus associated with intracranial schwannomas: hyperproteinorrhachia as an etiopathological factor?. Acta Neurochir (Wien) 2003; 145 (01) 73-78
- 10 Al Hinai Q, Zeitouni A, Sirhan D. et al. Communicating hydrocephalus and vestibular schwannomas: etiology, treatment, and long-term follow-up. J Neurol Surg B Skull Base 2013; 74 (02) 68-74
- 11 Rogg JM, Ahn SH, Tung GA, Reinert SE, Norén G. Prevalence of hydrocephalus in 157 patients with vestibular schwannoma. Neuroradiology 2005; 47 (05) 344-351
- 12 Rogers NK, Brand CS. Acoustic neuroma may impair vision. BMJ 1996; 312 (7029): 511
- 13 van Meter WS, Younge BR, Harner SG. Ophthalmic manifestations of acoustic neurinoma. Ophthalmology 1983; 90 (08) 917-922
- 14 Grainger J, Dias PS. Case report: optic disc edema without hydrocephalus in acoustic neuroma. Skull Base 2005; 15 (01) 83-86 , discussion 86–88
- 15 Candanedo C, Moscovici S, Kruger JM, Mizrachi CJ, Eliahou R, Spektor S. Vestibular schwannoma presenting with bilateral papilledema without hydrocephalus: case study. Cureus 2017; 9 (11) e1862
- 16 Matos RJ, Gil PN, Pires JM, Lopes N. Advanced vestibular schwannoma: a case of optic disc oedema without hydrocephalus. Neuroophthalmology 2016; 40 (05) 222-224
- 17 Miyakoshi A, Kohno M, Nagata O, Sora S, Sato H. Hydrocephalus associated with vestibular schwannomas: perioperative changes in cerebrospinal fluid. Acta Neurochir (Wien) 2013; 155 (07) 1271-1276
- 18 Norén G. Long-term complications following gamma knife radiosurgery of vestibular schwannomas. Stereotact Funct Neurosurg 1998; 70 (Suppl. 01) 65-73
- 19 Briggs RJ, Shelton C, Kwartler JA, Hitselberger W. Management of hydrocephalus resulting from acoustic neuromas. Otolaryngol Head Neck Surg 1993; 109 (06) 1020-1024
- 20 Prabhuraj AR, Sadashiva N, Kumar S. et al. Hydrocephalus associated with large vestibular schwannoma: management options and factors predicting requirement of cerebrospinal fluid diversion after primary surgery. J Neurosci Rural Pract 2017; 8 (Suppl. 01) S27-S32
- 21 Mautner VF, Baser ME, Thakkar SD, Feigen UM, Friedman JM, Kluwe L. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study. J Neurosurg 2002; 96 (02) 223-228